Atrasentan hydrochloride (ABT-627 hydrochloride) is a potent, orally active, selective endothelin A (ETA) receptor antagonist that inhibits ETA activity and blocks endothelin-induced cellular proliferation with an IC50 value of 0.0551 nM. It can be used in studies related to prostate cancer as well as IgA nephropathy (IgAN). It can be used in prostate cancer and IgA nephropathy (IgAN) related studies.
Molecular Weight:
547.08
Purity:
>98%
CAS Number:
[195733-43-8]
Formula:
C29H38N2O6 HCl
Target:
Endothelin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted